Ratio of Anogenital Warts Between Different Anatomical Sites in Homosexual and Heterosexual Individuals in Australia, 2002-2013: Implications for Susceptibility of Different Anatomical Sites to Genital Warts

Overview

Journal Epidemiol Infect

Publisher Cambridge University Press

Specialties Infectious Diseases
Public Health

Date 2015 Apr 4

PMID 25835345

Citations 6

Authors

E P F Chow

A C Lin

T R H Read

C S Bradshaw

M Y Chen

C K Fairley

Affiliations

Soon will be listed here.

Abstract

There is little known regarding the transmissibility of human papillomavirus (HPV) between different sites in men who have sex with men (MSM) and heterosexual individuals. We conducted a retrospective analysis investigating all new patients attending the Melbourne Sexual Health Centre in Australia between 2002 and 2013. We describe the prevalence and ratio of the first episode of anogenital warts in MSM and heterosexual males and females. The proportion of new MSM clients with anal and penile warts was 4·0% (362/8978) and 1·6% (141/8978), respectively; which gave an anal-to-penile wart ratio of 1:2·6. About 13·7% (1656/12112) of heterosexual males had penile warts and 10·0% (1121/11166) of females had vulval warts, which yielded a penile-to-vulval wart ratio of 1:0·7. Penile-anal transmission has a higher ratio than penile-vulval transmission, suggesting that the anal epithelium may be more susceptible to HPV infection than the vulval epithelium in females; these ratios are important in modelling the control of HPV in MSM.

Citing Articles

Sustained Decline in Hospitalisations for Anogenital Warts in Australia: Analysis of National Hospital Morbidity Data 2003-2020.

Rashid H, Dey A, Wang H, Beard F Trop Med Infect Dis. 2024; 9(4).

PMID: 38668540 PMC: 11055050. DOI: 10.3390/tropicalmed9040079.

Prevalence and factors associated with anogenital warts among sexual and gender minorities attending a trusted community health center in Lagos, Nigeria.

Adebajo S, Nowak R, Adebiyi R, Shoyemi E, Ekeh C, Ramadhani H PLOS Glob Public Health. 2023; 2(11):e0001215.

PMID: 36962635 PMC: 10021808. DOI: 10.1371/journal.pgph.0001215.

Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review.

King L, Lewnard J, Niccolai L Open Forum Infect Dis. 2023; 10(1):ofad004.

PMID: 36726535 PMC: 9887268. DOI: 10.1093/ofid/ofad004.

Combining aminolaevulinic acid photodynamic therapy with carbon dioxide laser therapy to treat adult-onset laryngeal papillomatosis: case reports and a literature review.

Li Y, Wei F Transl Cancer Res. 2022; 10(7):3576-3581.

PMID: 35116660 PMC: 8799196. DOI: 10.21037/tcr-20-2985.

Risk of Anogenital Warts in Renal Transplant Recipients Compared with Immunocompetent Controls: A Cross-sectional Clinical Study.

Larsen H, Thomsen L, Haedersdal M, Lok T, Hansen J, Schwartz Sorensen S Acta Derm Venereol. 2021; 101(7):adv00497.

PMID: 34184064 PMC: 9413648. DOI: 10.2340/00015555-3858.

References

Brotherton J, Murray S, Hall M, Andrewartha L, Banks C, Meijer D . Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust. 2013; 199(9):614-7. DOI: 10.5694/mja13.10272. View

Clemens J, Shin S, Ali M . New approaches to the assessment of vaccine herd protection in clinical trials. Lancet Infect Dis. 2011; 11(6):482-7. DOI: 10.1016/S1473-3099(10)70318-2. View

Ali H, Donovan B, Wand H, Read T, Regan D, Grulich A . Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ. 2013; 346:f2032. DOI: 10.1136/bmj.f2032. View

Winer R, Kiviat N, Hughes J, Adam D, Lee S, Kuypers J . Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis. 2005; 191(5):731-8. DOI: 10.1086/427557. View

Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

Antonsson A, Cornford M, Perry S, Davis M, Dunne M, Whiteman D . Prevalence and risk factors for oral HPV infection in young Australians. PLoS One. 2014; 9(3):e91761. PMC: 3956721. DOI: 10.1371/journal.pone.0091761. View

Lawton M, Nathan M, Asboe D . HPV vaccination to prevent anal cancer in men who have sex with men. Sex Transm Infect. 2013; 89(5):342-3. DOI: 10.1136/sextrans-2013-051176. View

Phang C, Hocking J, Fairley C, Bradshaw C, Hayes P, Chen M . More than just anal sex: the potential for sexually transmitted infection transmission among men visiting sex-on-premises venues. Sex Transm Infect. 2008; 84(3):217-9. DOI: 10.1136/sti.2007.028787. View

Zou H, Tabrizi S, Grulich A, Garland S, Hocking J, Bradshaw C . Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. J Infect Dis. 2013; 209(5):642-51. DOI: 10.1093/infdis/jit626. View

10.

Lyons A, Pitts M, Grierson J, Smith A, Mcnally S, Couch M . Sexual behavior and HIV testing among bisexual men: a nationwide comparison of Australian bisexual-identifying and gay-identifying men. AIDS Behav. 2012; 16(7):1934-43. DOI: 10.1007/s10461-012-0148-7. View

11.

Read T, Hocking J, Chen M, Donovan B, Bradshaw C, Fairley C . The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011; 87(7):544-7. DOI: 10.1136/sextrans-2011-050234. View

12.

Machalek D, Poynten M, Jin F, Fairley C, Farnsworth A, Garland S . Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012; 13(5):487-500. DOI: 10.1016/S1470-2045(12)70080-3. View

13.

Tabrizi S, Brotherton J, Kaldor J, Skinner S, Cummins E, Liu B . Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis. 2012; 206(11):1645-51. DOI: 10.1093/infdis/jis590. View

14.

Georgousakis M, Jayasinghe S, Brotherton J, Gilroy N, Chiu C, Macartney K . Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study. Lancet Infect Dis. 2012; 12(8):627-34. DOI: 10.1016/S1473-3099(12)70031-2. View

15.

Garnett G . Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis. 2005; 191 Suppl 1:S97-106. DOI: 10.1086/425271. View

16.

Fethers K, Fairley C, Morton A, Hocking J, Hopkins C, Kennedy L . Early sexual experiences and risk factors for bacterial vaginosis. J Infect Dis. 2009; 200(11):1662-70. DOI: 10.1086/648092. View

17.

Jin F, Prestage G, Kippax S, Pell C, Donovan B, Templeton D . Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study. Sex Transm Dis. 2006; 34(7):488-93. DOI: 10.1097/01.olq.0000245960.52668.e5. View